Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 1.43% | 89.63 | 1.3% | $877.94m | |
| AMGN | Amgen Inc. | 0.40% | 191.89 | 1.2% | $550.47m | |
| GILD | Gilead Sciences, Inc. | 0.50% | 64.92 | 0.9% | $461.62m | |
| BIIB | Biogen Inc. | -29.23% | 226.88 | 1.3% | $457.10m | |
| ONCE | Spark Therapeutics, Inc. | -0.20% | 113.27 | 11.2% | $443.03m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.72% | 402.59 | 2.6% | $280.51m | |
| ILMN | Illumina, Inc. | 1.24% | 319.21 | 3.5% | $280.06m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.43% | 182.56 | 1.9% | $232.81m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.27% | 126.66 | 15.4% | $211.90m | |
| EXAS | Exact Sciences Corporation | 1.70% | 92.02 | 25.3% | $191.93m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.94% | 134.21 | 2.0% | $186.57m | |
| BPTH | Bio-Path Holdings, Inc. | -14.05% | 18.48 | 190.1% | $182.12m | |
| A | Agilent Technologies, Inc. | 1.34% | 82.00 | 1.6% | $143.35m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.36% | 80.50 | 8.3% | $105.13m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.91% | 90.78 | 4.3% | $95.05m |
Company Profile
SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutic for a broad range of indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, which targets the Wilms tumor 1, or WT1, protein. The company was founded on April 3, 2006 and is headquartered in New York, NY.